Jeffrey C. Nolz

2.6k citations
35 papers · 2.0k indexed · h-index 23

Jeffrey C. Nolz

35 papers receiving 2.0k citations

Peers

Jeffrey C. Nolz
Comparison fields: 5 of 88
  • Immunology 1.5k
  • Immunology and Allergy 301
  • Virology 79
  • Oncology 430
  • Cell Biology 219
Replace Yolanda R. Carrasco with:
Yolanda R. Carrasco Spain
Vincenzo Di Bartolo France
Karine Chemin Sweden
Tomoya Katakai Japan
Naomi E. Harwood United Kingdom
Francesco Marangoni United States
Julie Harriague France
Jason S. Mitchell United States
Jordan Jacobelli United States
Jan Jongstra Canada
Jeffrey C. Nolz relative to Yolanda R. Carrasco Spain Yolanda R. Carrasco's profile →
Citations per field
00.5×1.5×1.8×
Yolanda R. Carrasco · 1×
Citations per year

Countries citing papers authored by Jeffrey C. Nolz

Since Specialization
Citations

This map shows the geographic impact of Jeffrey C. Nolz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C. Nolz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C. Nolz more than expected).

Fields of papers citing papers by Jeffrey C. Nolz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey C. Nolz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C. Nolz. The network helps show where Jeffrey C. Nolz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jeffrey C. Nolz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeffrey C. Nolz Line = papers co-authored together Jeffrey C. Nolz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202316
2 20233
3 202229
4 20224
5 202021
6 201916
7 201945
8 201738
9 201735
10 20179
11 201479
12 2012114
13 201190
14 201157
15 2011118
16 2007295
17 2006163
18 2006197
19 200524
20 200570

About Jeffrey C. Nolz

Jeffrey C. Nolz is a scholar working on Immunology, Immunology and Allergy and Virology, having authored 35 papers that have together received 2.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (23 papers), Immune Cell Function and Interaction (17 papers), Immunotherapy and Immune Responses (15 papers), Cell Adhesion Molecules Research (6 papers), Glycosylation and Glycoproteins Research (3 papers), Poxvirus research and outbreaks (3 papers), Galectins and Cancer Biology (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Immunology (1.5k citations), Immunology and Allergy (301 citations) and Virology (79 citations). Jeffrey C. Nolz has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include John T. Harty, Daniel D. Billadeau, Timothy S. Gomez, Martin J. Richer, Bruce D. Freedman, Peimin Zhu, Yoji Shimizu, Ricardo B. Medeiros, Jana L. Mooster and Samuel J. Hobbs. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026